Cerevance’s Post

👁 Rare Disease Spotlight : Bietti’s Crystalline Dystrophy 👁 🔍 Key Features: 1. Crystal deposits in the retina. 2. Night blindness and peripheral vision loss. 3. Central vision deterioration over time. 🌐 Diagnosis & Management: Early detection is vital. Ophthalmologists use clinical exams and genetic testing. While there's no cure, management focuses on symptom relief and slowing progression. #BiettisCrystallineDystrophy #RareDiseases #VisionHealth #Ophthalmology #MedicalAwareness #GeneticDisorders

🔬 Lab Update! 🔬 We're using our MI-SIM super-resolution microscope to track autophagy in lysosomes and mitochondria, revealing new details about cellular health and disease mechanisms. Make sure you click ‘follow’ to stay up to date with all the latest from us! #CellBiology #SuperResolutionMicroscopy #Mitophagy #Autophagy #ScientificResearch

PD has few overlapping phenotypes and knowledge and expertise ,powered by AI, plays a pivotal role in getting a good diagnosis and reduce the miss outs. Identify, diagnose and Treat along with prevention are key to the management of the disease.

Parkinson's disease (PD) affects over 10 million people worldwide and costs nearly $25 billion annually in the United States alone. This progressive disorder, caused by the degeneration of dopamine-producing cells in the brain, has both genetic and environmental contributors, with recent studies even implicating the gut microbiome. The Michael J. Fox Foundation for Parkinson's Research and Taconic Biosciences are committed to advancing research to develop better therapies. Today, we are excited to introduce the Floxed Parkin mouse, a new model to accelerate Parkinson’s research and improve patient outcomes. Learn more: https://bit.ly/4bOeIBZ

AxoSim's microBrain™ organoids can be used to simulate various neurodevelopmental and degenerative diseases. Here, we've grown organoids using iPSCs from a healthy donor (Control) and those of a patient with CDKL5 Deficiency Disorder (CDKL5 KO). While neurons (green) and astrocytes (magenta) develop normally, the CDD organoids show a dramatic hyperactivity phenotype that can be measured via high throughput calcium imaging. #revvity #microscopymonday #fromthelab #organoids #cdkl5 #humanorganoids

Spotlight: you can now use CDC’s new app to collect family health history to help you understand your risk of hereditary cancers such as breast, colon, and pancreatic. #cancer #precisionmedicine #screening

📢 Check out our latest poster presented at #AAIC24! Last week at AAIC 2024, we showcased our research on aging-associated neurodegeneration (ND) as a leading risk factor for Alzheimer's (AD) and Parkinson's (PD). Discover how Biognosys addresses early ND pathology with an innovative discovery workflow that utilizes quantitative #proteomics from paired #CSF and #plasma samples. 📥 Download the poster here: https://lnkd.in/dVGUkgfB #Agining #AlzheimersResearch #Biomarkers #DrugDiscovery

Progress in translational research has been impeded by a lack of highly multiplexed and ultrasensitive proteomic technologies. #NULISA is addressing this challenge and changing the way we profile proteins from biofluids. Stop by our poster this week at Keystone Symposia's meeting on Neurodegenerative Diseases in Santa Fe, NM. Meet with Douglas Hinerfeld and Max Mahoney learn more! https://ow.ly/bW5O50S6rgx #KSNeurodegen24

Lung cancer hits communities of color harder – and not just smokers. Family history, genetics and environmental exposure are risk factors that can lead to #lungcancer. Know YOUR risks and talk to your doctor about #prevention, #earlydetection and regular #screening. Follow our #spotlight series this #lungcancerawarenessmonth to learn more from top doctors in our communities. #LCAM #healthequity #enddisparitiesnow